chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Arthralgia, Asthenia, Chills, Confusional state
Clinical narrative: hallucinations; Severe pain unable to lift left arm; severe body/joint aches; severe body/joint aches; severe headache; black spots in vision; weakness; fatigue; insomnia; confusion; nausea; stomach pain; chills; fever; Pregnancy at time of Vaccination: Yes; This is a spontaneous report from a contactable consumer reported for herself. This 34-year-old female patient received the 2nd dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine) via an unspecified route of administration in the left arm on 28Apr2021 01:00 PM at the same age as single dose for COVID-19 immunisation. Medical history included Leiden factor V and pregnancy. Concomitant medications included minerals nos/vitamins nos (PRENATAL VITAMINS), folic acid, labetalol, acetylsalicylic acid (ASPIRIN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the 1st dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine) on 01Apr2021 at 03:00 PM for COVID-19 immunisation, experiencing exposure during pregnancy; received amoxicillin;clavulanic acid (AUGMENTIN) experiencing severe vomiting but not an anaphylactic reaction. The patient experienced severe pain unable to lift left arm, severe body/joint aches, severe headache, black spots in vision, weakness, fatigue, insomnia, confusion, nausea, stomach pain, chills, fever, hallucinations; on 29Apr2021 at 04:00 am. The patient was pregnancy at time of vaccination. Pregnancy due date was 23Aug2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the event exposure during pregnancy was unknown, of the other events was recovering.   Information on the lot/batch number has been requested.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Exposure during pregnancy, Fatigue, Hallucination, Headache, Insomnia
Clinical narrative: hallucinations; Severe pain unable to lift left arm; severe body/joint aches; severe body/joint aches; severe headache; black spots in vision; weakness; fatigue; insomnia; confusion; nausea; stomach pain; chills; fever; Pregnancy at time of Vaccination: Yes; This is a spontaneous report from a contactable consumer reported for herself. This 34-year-old female patient received the 2nd dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine) via an unspecified route of administration in the left arm on 28Apr2021 01:00 PM at the same age as single dose for COVID-19 immunisation. Medical history included Leiden factor V and pregnancy. Concomitant medications included minerals nos/vitamins nos (PRENATAL VITAMINS), folic acid, labetalol, acetylsalicylic acid (ASPIRIN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the 1st dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine) on 01Apr2021 at 03:00 PM for COVID-19 immunisation, experiencing exposure during pregnancy; received amoxicillin;clavulanic acid (AUGMENTIN) experiencing severe vomiting but not an anaphylactic reaction. The patient experienced severe pain unable to lift left arm, severe body/joint aches, severe headache, black spots in vision, weakness, fatigue, insomnia, confusion, nausea, stomach pain, chills, fever, hallucinations; on 29Apr2021 at 04:00 am. The patient was pregnancy at time of vaccination. Pregnancy due date was 23Aug2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the event exposure during pregnancy was unknown, of the other events was recovering.   Information on the lot/batch number has been requested.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Pain in extremity, Pyrexia, Visual impairment
Clinical narrative: hallucinations; Severe pain unable to lift left arm; severe body/joint aches; severe body/joint aches; severe headache; black spots in vision; weakness; fatigue; insomnia; confusion; nausea; stomach pain; chills; fever; Pregnancy at time of Vaccination: Yes; This is a spontaneous report from a contactable consumer reported for herself. This 34-year-old female patient received the 2nd dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine) via an unspecified route of administration in the left arm on 28Apr2021 01:00 PM at the same age as single dose for COVID-19 immunisation. Medical history included Leiden factor V and pregnancy. Concomitant medications included minerals nos/vitamins nos (PRENATAL VITAMINS), folic acid, labetalol, acetylsalicylic acid (ASPIRIN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the 1st dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine) on 01Apr2021 at 03:00 PM for COVID-19 immunisation, experiencing exposure during pregnancy; received amoxicillin;clavulanic acid (AUGMENTIN) experiencing severe vomiting but not an anaphylactic reaction. The patient experienced severe pain unable to lift left arm, severe body/joint aches, severe headache, black spots in vision, weakness, fatigue, insomnia, confusion, nausea, stomach pain, chills, fever, hallucinations; on 29Apr2021 at 04:00 am. The patient was pregnancy at time of vaccination. Pregnancy due date was 23Aug2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the event exposure during pregnancy was unknown, of the other events was recovering.   Information on the lot/batch number has been requested.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Chills, Hyperhidrosis, Hypoaesthesia, Nausea
Clinical narrative: fever spiked to 103.7 from a normal of about 97.3; Sore left arm, armpit/ache in forearm; Sore left arm, armpit; Numbness/ache in forearm, slight numbness in hand; bad chills; lot of sweating starting that evening and continuing; runny nose; nausea; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 27Apr2021 15:00 (Lot Number: EW0170) as 2nd dose, single for COVID-19 immunisation. Medical history included chronic lymphocitic leukemia, Known allergies to environmental. Concomitant medications included atorvastatin; azelastine; fluticasone propionate (FLONASE ALLERGY RELIEF); metformin, all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162B2 (lot number: EW0150) for Covid-19 immunisation on 06Apr2021 in left arm at the age of 59-year-old. The patient experienced sore left arm, armpit, numbness/ache in forearm, slight numbness in hand. bad chills, lot of sweating starting that evening and continuing, a runny nose, nausea, fever spiked to 103.7 from a normal of about 97.3 at about the 23 hour mark, since 27Apr2021 21:00. As of right now 30Apr21 14:21, 3 days later, the patient was still a little sweaty, armpit and arm sore, forearm still ache and hand still a little numb. Since the vaccination, the patient has not been tested for COVID-19. There was no treatment received. Adverse events resulted in Emergency room/department or urgent care. The outcome of events was recovering.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia, Rhinorrhoea
Clinical narrative: fever spiked to 103.7 from a normal of about 97.3; Sore left arm, armpit/ache in forearm; Sore left arm, armpit; Numbness/ache in forearm, slight numbness in hand; bad chills; lot of sweating starting that evening and continuing; runny nose; nausea; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 27Apr2021 15:00 (Lot Number: EW0170) as 2nd dose, single for COVID-19 immunisation. Medical history included chronic lymphocitic leukemia, Known allergies to environmental. Concomitant medications included atorvastatin; azelastine; fluticasone propionate (FLONASE ALLERGY RELIEF); metformin, all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162B2 (lot number: EW0150) for Covid-19 immunisation on 06Apr2021 in left arm at the age of 59-year-old. The patient experienced sore left arm, armpit, numbness/ache in forearm, slight numbness in hand. bad chills, lot of sweating starting that evening and continuing, a runny nose, nausea, fever spiked to 103.7 from a normal of about 97.3 at about the 23 hour mark, since 27Apr2021 21:00. As of right now 30Apr21 14:21, 3 days later, the patient was still a little sweaty, armpit and arm sore, forearm still ache and hand still a little numb. Since the vaccination, the patient has not been tested for COVID-19. There was no treatment received. Adverse events resulted in Emergency room/department or urgent care. The outcome of events was recovering.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Body temperature, Chills, Hyperhidrosis, Hypoaesthesia
Clinical narrative: fever spiked to 103.7 from a normal of about 97.3; Sore left arm, armpit/ache in forearm; Sore left arm, armpit; Numbness/ache in forearm, slight numbness in hand; bad chills; lot of sweating starting that evening and continuing; runny nose; nausea; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 27Apr2021 15:00 (Lot Number: EW0170) as 2nd dose, single for COVID-19 immunisation. Medical history included chronic lymphocitic leukemia, Known allergies to environmental. Concomitant medications included atorvastatin; azelastine; fluticasone propionate (FLONASE ALLERGY RELIEF); metformin, all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162B2 (lot number: EW0150) for Covid-19 immunisation on 06Apr2021 in left arm at the age of 59-year-old. The patient experienced sore left arm, armpit, numbness/ache in forearm, slight numbness in hand. bad chills, lot of sweating starting that evening and continuing, a runny nose, nausea, fever spiked to 103.7 from a normal of about 97.3 at about the 23 hour mark, since 27Apr2021 21:00. As of right now 30Apr21 14:21, 3 days later, the patient was still a little sweaty, armpit and arm sore, forearm still ache and hand still a little numb. Since the vaccination, the patient has not been tested for COVID-19. There was no treatment received. Adverse events resulted in Emergency room/department or urgent care. The outcome of events was recovering.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia, Rhinorrhoea
Clinical narrative: fever spiked to 103.7 from a normal of about 97.3; Sore left arm, armpit/ache in forearm; Sore left arm, armpit; Numbness/ache in forearm, slight numbness in hand; bad chills; lot of sweating starting that evening and continuing; runny nose; nausea; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 27Apr2021 15:00 (Lot Number: EW0170) as 2nd dose, single for COVID-19 immunisation. Medical history included chronic lymphocitic leukemia, Known allergies to environmental. Concomitant medications included atorvastatin; azelastine; fluticasone propionate (FLONASE ALLERGY RELIEF); metformin, all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162B2 (lot number: EW0150) for Covid-19 immunisation on 06Apr2021 in left arm at the age of 59-year-old. The patient experienced sore left arm, armpit, numbness/ache in forearm, slight numbness in hand. bad chills, lot of sweating starting that evening and continuing, a runny nose, nausea, fever spiked to 103.7 from a normal of about 97.3 at about the 23 hour mark, since 27Apr2021 21:00. As of right now 30Apr21 14:21, 3 days later, the patient was still a little sweaty, armpit and arm sore, forearm still ache and hand still a little numb. Since the vaccination, the patient has not been tested for COVID-19. There was no treatment received. Adverse events resulted in Emergency room/department or urgent care. The outcome of events was recovering.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, C-reactive protein increased, Capillary nail refill test abnormal, Dyskinesia, Hypoaesthesia
Clinical narrative: Slow cap refill in feet, knees, inside ankle -L/R sides; Numbness, starting in toes, ascending to knees, thighs.; Mottling on feet, interior ankles, kneecaps; Bilateral decreased sensation from the toes up to the hip, with intact strength, with 2-3 beats of clonus bilaterally.; Mottling on feet, interior ankles, kneecaps, along with blanching redness.; Mottling on feet, interior ankles, kneecaps, along with blanching redness.; with 2-3 beats of clonus bilaterally; This is a spontaneous report from a contactable consumer (patient). A 22-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 01Apr2021 09:30 (Lot Number: ER8734) as 1st dose, single for COVID-19 immunisation. There was no medical history and no known allergies. Concomitant medications included paroxetine taken for an unspecified indication, within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced Slow cap refill in feet, knees, inside ankle - L/R sides; Numbness, starting in toes, ascending to knees, thighs; Mottling on feet, interior ankles, kneecaps, along with blanching redness; Bilateral decreased sensation from the toes up to the hip, with intact strength, with 2-3 beats of clonus bilaterally, 2+ reflexes in lower extremities, No cold sensation below the ankles bilaterally. Adverse events started on 16Apr2021. The adverse events result in Emergency room/department or urgent care. The patient was hospitalized for the reported events for 3 days. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included COVID-19 PCR-Nasal Swab: negative on 13Apr2021, COVID-19 rt-PCR-Nasal Swab: negative on 27Apr2021. There was no treatment received. The outcome of events was not recovered.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Livedo reticularis, Lumbar puncture normal, Magnetic resonance imaging head normal, Magnetic resonance imaging normal, Magnetic resonance imaging spinal normal
Clinical narrative: Slow cap refill in feet, knees, inside ankle -L/R sides; Numbness, starting in toes, ascending to knees, thighs.; Mottling on feet, interior ankles, kneecaps; Bilateral decreased sensation from the toes up to the hip, with intact strength, with 2-3 beats of clonus bilaterally.; Mottling on feet, interior ankles, kneecaps, along with blanching redness.; Mottling on feet, interior ankles, kneecaps, along with blanching redness.; with 2-3 beats of clonus bilaterally; This is a spontaneous report from a contactable consumer (patient). A 22-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 01Apr2021 09:30 (Lot Number: ER8734) as 1st dose, single for COVID-19 immunisation. There was no medical history and no known allergies. Concomitant medications included paroxetine taken for an unspecified indication, within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced Slow cap refill in feet, knees, inside ankle - L/R sides; Numbness, starting in toes, ascending to knees, thighs; Mottling on feet, interior ankles, kneecaps, along with blanching redness; Bilateral decreased sensation from the toes up to the hip, with intact strength, with 2-3 beats of clonus bilaterally, 2+ reflexes in lower extremities, No cold sensation below the ankles bilaterally. Adverse events started on 16Apr2021. The adverse events result in Emergency room/department or urgent care. The patient was hospitalized for the reported events for 3 days. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included COVID-19 PCR-Nasal Swab: negative on 13Apr2021, COVID-19 rt-PCR-Nasal Swab: negative on 27Apr2021. There was no treatment received. The outcome of events was not recovered.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myoclonus, Peripheral coldness, Sensory loss, Skin discolouration
Clinical narrative: Slow cap refill in feet, knees, inside ankle -L/R sides; Numbness, starting in toes, ascending to knees, thighs.; Mottling on feet, interior ankles, kneecaps; Bilateral decreased sensation from the toes up to the hip, with intact strength, with 2-3 beats of clonus bilaterally.; Mottling on feet, interior ankles, kneecaps, along with blanching redness.; Mottling on feet, interior ankles, kneecaps, along with blanching redness.; with 2-3 beats of clonus bilaterally; This is a spontaneous report from a contactable consumer (patient). A 22-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 01Apr2021 09:30 (Lot Number: ER8734) as 1st dose, single for COVID-19 immunisation. There was no medical history and no known allergies. Concomitant medications included paroxetine taken for an unspecified indication, within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced Slow cap refill in feet, knees, inside ankle - L/R sides; Numbness, starting in toes, ascending to knees, thighs; Mottling on feet, interior ankles, kneecaps, along with blanching redness; Bilateral decreased sensation from the toes up to the hip, with intact strength, with 2-3 beats of clonus bilaterally, 2+ reflexes in lower extremities, No cold sensation below the ankles bilaterally. Adverse events started on 16Apr2021. The adverse events result in Emergency room/department or urgent care. The patient was hospitalized for the reported events for 3 days. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included COVID-19 PCR-Nasal Swab: negative on 13Apr2021, COVID-19 rt-PCR-Nasal Swab: negative on 27Apr2021. There was no treatment received. The outcome of events was not recovered.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Clonus, Erythema, Hypoaesthesia, Livedo reticularis, Pallor
Clinical narrative: Slow cap refill in feet, knees, inside ankle -L/R sides; Numbness, starting in toes, ascending to knees, thighs.; Mottling on feet, interior ankles, kneecaps; Bilateral decreased sensation from the toes up to the hip, with intact strength, with 2-3 beats of clonus bilaterally.; Mottling on feet, interior ankles, kneecaps, along with blanching redness.; Mottling on feet, interior ankles, kneecaps, along with blanching redness.; with 2-3 beats of clonus bilaterally; This is a spontaneous report from a contactable consumer (patient). A 22-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 01Apr2021 09:30 (Lot Number: ER8734) as 1st dose, single for COVID-19 immunisation. There was no medical history and no known allergies. Concomitant medications included paroxetine taken for an unspecified indication, within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced Slow cap refill in feet, knees, inside ankle - L/R sides; Numbness, starting in toes, ascending to knees, thighs; Mottling on feet, interior ankles, kneecaps, along with blanching redness; Bilateral decreased sensation from the toes up to the hip, with intact strength, with 2-3 beats of clonus bilaterally, 2+ reflexes in lower extremities, No cold sensation below the ankles bilaterally. Adverse events started on 16Apr2021. The adverse events result in Emergency room/department or urgent care. The patient was hospitalized for the reported events for 3 days. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included COVID-19 PCR-Nasal Swab: negative on 13Apr2021, COVID-19 rt-PCR-Nasal Swab: negative on 27Apr2021. There was no treatment received. The outcome of events was not recovered.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Reflex test, SARS-CoV-2 test, Sensory loss, Vascular test abnormal
Clinical narrative: Slow cap refill in feet, knees, inside ankle -L/R sides; Numbness, starting in toes, ascending to knees, thighs.; Mottling on feet, interior ankles, kneecaps; Bilateral decreased sensation from the toes up to the hip, with intact strength, with 2-3 beats of clonus bilaterally.; Mottling on feet, interior ankles, kneecaps, along with blanching redness.; Mottling on feet, interior ankles, kneecaps, along with blanching redness.; with 2-3 beats of clonus bilaterally; This is a spontaneous report from a contactable consumer (patient). A 22-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 01Apr2021 09:30 (Lot Number: ER8734) as 1st dose, single for COVID-19 immunisation. There was no medical history and no known allergies. Concomitant medications included paroxetine taken for an unspecified indication, within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced Slow cap refill in feet, knees, inside ankle - L/R sides; Numbness, starting in toes, ascending to knees, thighs; Mottling on feet, interior ankles, kneecaps, along with blanching redness; Bilateral decreased sensation from the toes up to the hip, with intact strength, with 2-3 beats of clonus bilaterally, 2+ reflexes in lower extremities, No cold sensation below the ankles bilaterally. Adverse events started on 16Apr2021. The adverse events result in Emergency room/department or urgent care. The patient was hospitalized for the reported events for 3 days. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included COVID-19 PCR-Nasal Swab: negative on 13Apr2021, COVID-19 rt-PCR-Nasal Swab: negative on 27Apr2021. There was no treatment received. The outcome of events was not recovered.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Dyspnoea, Fatigue, Joint stiffness, Limb discomfort
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 27Apr2021 (at the age of 60-years-old) as a single dose for COVID-19 immunization. Medical history included ongoing tremors and prostate issue. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included clonazepam, tamsulosin, oxybutynin. The patient did not receive any other vaccinations within 4 weeks of the vaccine. On 27Apr2021 (the first day), the patient was a little tired. On 28Apr2021 (the second day), the patient experienced joint pain, felt very tired and weak. By 19:00-20:00, the patient realized he was going to have a tremor attack, but quickly turned into what would be called a seizure. The patient lost motor skills, speaking and breathing issues accrued. The symptoms where coming and going. With the help of his wife, the patient managed to take one 0.5 mg clonazepam. The situation lasted for around an hour, after which the patient went to bed. The next morning, 29Apr2021, the patient still had a lot of joint and muscle pain. As soon as he tried to start some minor work around the house, the tremors started again, but this time the patient took clonazepam and rested in bed all day. Today, 30Apr2021, the patient was tired from the situation and will be resting also. Since the vaccination, the patient was not tested for COVID-19. The clinical outcome of seizure, " tremor attack / tremors started again", joint pain, tired, weak, lost motor skills, speaking and breathing issues accrued and muscle pain was resolving.  Information about lot/batch number requested.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nervousness, Pain, Seizure, Speech disorder, Tremor
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 27Apr2021 (at the age of 60-years-old) as a single dose for COVID-19 immunization. Medical history included ongoing tremors and prostate issue. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included clonazepam, tamsulosin, oxybutynin. The patient did not receive any other vaccinations within 4 weeks of the vaccine. On 27Apr2021 (the first day), the patient was a little tired. On 28Apr2021 (the second day), the patient experienced joint pain, felt very tired and weak. By 19:00-20:00, the patient realized he was going to have a tremor attack, but quickly turned into what would be called a seizure. The patient lost motor skills, speaking and breathing issues accrued. The symptoms where coming and going. With the help of his wife, the patient managed to take one 0.5 mg clonazepam. The situation lasted for around an hour, after which the patient went to bed. The next morning, 29Apr2021, the patient still had a lot of joint and muscle pain. As soon as he tried to start some minor work around the house, the tremors started again, but this time the patient took clonazepam and rested in bed all day. Today, 30Apr2021, the patient was tired from the situation and will be resting also. Since the vaccination, the patient was not tested for COVID-19. The clinical outcome of seizure, " tremor attack / tremors started again", joint pain, tired, weak, lost motor skills, speaking and breathing issues accrued and muscle pain was resolving.  Information about lot/batch number requested.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Dyspnoea, Fatigue, Motor dysfunction
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 27Apr2021 (at the age of 60-years-old) as a single dose for COVID-19 immunization. Medical history included ongoing tremors and prostate issue. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included clonazepam, tamsulosin, oxybutynin. The patient did not receive any other vaccinations within 4 weeks of the vaccine. On 27Apr2021 (the first day), the patient was a little tired. On 28Apr2021 (the second day), the patient experienced joint pain, felt very tired and weak. By 19:00-20:00, the patient realized he was going to have a tremor attack, but quickly turned into what would be called a seizure. The patient lost motor skills, speaking and breathing issues accrued. The symptoms where coming and going. With the help of his wife, the patient managed to take one 0.5 mg clonazepam. The situation lasted for around an hour, after which the patient went to bed. The next morning, 29Apr2021, the patient still had a lot of joint and muscle pain. As soon as he tried to start some minor work around the house, the tremors started again, but this time the patient took clonazepam and rested in bed all day. Today, 30Apr2021, the patient was tired from the situation and will be resting also. Since the vaccination, the patient was not tested for COVID-19. The clinical outcome of seizure, " tremor attack / tremors started again", joint pain, tired, weak, lost motor skills, speaking and breathing issues accrued and muscle pain was resolving.  Information about lot/batch number requested.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Seizure, Speech disorder, Tremor
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 27Apr2021 (at the age of 60-years-old) as a single dose for COVID-19 immunization. Medical history included ongoing tremors and prostate issue. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included clonazepam, tamsulosin, oxybutynin. The patient did not receive any other vaccinations within 4 weeks of the vaccine. On 27Apr2021 (the first day), the patient was a little tired. On 28Apr2021 (the second day), the patient experienced joint pain, felt very tired and weak. By 19:00-20:00, the patient realized he was going to have a tremor attack, but quickly turned into what would be called a seizure. The patient lost motor skills, speaking and breathing issues accrued. The symptoms where coming and going. With the help of his wife, the patient managed to take one 0.5 mg clonazepam. The situation lasted for around an hour, after which the patient went to bed. The next morning, 29Apr2021, the patient still had a lot of joint and muscle pain. As soon as he tried to start some minor work around the house, the tremors started again, but this time the patient took clonazepam and rested in bed all day. Today, 30Apr2021, the patient was tired from the situation and will be resting also. Since the vaccination, the patient was not tested for COVID-19. The clinical outcome of seizure, " tremor attack / tremors started again", joint pain, tired, weak, lost motor skills, speaking and breathing issues accrued and muscle pain was resolving.  Information about lot/batch number requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Haemorrhage, Injection site swelling, Vaccination site haemorrhage
Clinical narrative: when it was administered her arm bled profusely, the lady who did it said she hit a blood vessel./significant amount of blood came out of her arm.,; when it was administered her arm bled profusely, the lady who did it said she hit a blood vessel.; when it was administered her arm bled profusely, the lady who did it said she hit a blood vessel.; This is a spontaneous report from a contactable consumer (patient)   A 49-years-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2ND DOSE, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced when it was administered her arm bled profusely, the lady who did it said she hit a blood vessel on an unspecified date. Caller just received second dose of covid vaccine. When it was administered her arm bled profusely. A significant amount of blood came out of her arm., the lady (person administering the vaccine)  who did it said she hit a blood vessel.  Caller wants to know if it will still be effective and if there will be any problems if it went into her blood stream. Caller would like to know if a blood vessel was hit inadvertently does it mean it hit the muscle if she would need to be revaccinated. The clinical outcome of the events was unknown.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site haemorrhage, Vascular injury, Wrong technique in product usage process
Clinical narrative: when it was administered her arm bled profusely, the lady who did it said she hit a blood vessel./significant amount of blood came out of her arm.,; when it was administered her arm bled profusely, the lady who did it said she hit a blood vessel.; when it was administered her arm bled profusely, the lady who did it said she hit a blood vessel.; This is a spontaneous report from a contactable consumer (patient)   A 49-years-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2ND DOSE, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced when it was administered her arm bled profusely, the lady who did it said she hit a blood vessel on an unspecified date. Caller just received second dose of covid vaccine. When it was administered her arm bled profusely. A significant amount of blood came out of her arm., the lady (person administering the vaccine)  who did it said she hit a blood vessel.  Caller wants to know if it will still be effective and if there will be any problems if it went into her blood stream. Caller would like to know if a blood vessel was hit inadvertently does it mean it hit the muscle if she would need to be revaccinated. The clinical outcome of the events was unknown.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling
Clinical narrative: allergic reaction; an infection in her arm; This is a spontaneous report from a contactable consumer (patient) reported that a 41-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), via an unspecified route of administration, administered in arm left on 22Apr2021 13:00 (at the age of 41-years-old) as 2nd dose, single for covid-19 immunization. The patient was not pregnant at the time of vaccination. The patient medical history included lupus, breast cancer and asthma; all from an unknown date. The patient had no known allergies. The patient had no covid-19 prior vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), administered in arm left on 01Apr2021 at 1:00 PM (at the age of 41-years-old) as 1st dose, single for covid-19 immunization. No other vaccine in four weeks and no other medications in two weeks. The patient's concomitant medications were not reported. The next day after receiving the second vaccine she ended up having an allergic reaction, which in turned into an infection in her arm on 23Apr2021 08:00. The events resulted in doctor or other health care professional office/clinic visit, emergency room/department or urgent care, hospitalization, prolongation of existing hospitalization (vaccine received during existing hospitalization). The patient was hospitalized for 3 days. The patient underwent lab tests and procedures which included sars-cov-2 test (nasal swab): unknown result (reported as pending) on 29Apr2021; and several tests: unknown results on Apr2021. The patient received antibiotics as treatment. The outcome of the events was not recovered.   Information about lot/batch number has been requested.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Investigation, Localised infection, SARS-CoV-2 test
Clinical narrative: allergic reaction; an infection in her arm; This is a spontaneous report from a contactable consumer (patient) reported that a 41-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), via an unspecified route of administration, administered in arm left on 22Apr2021 13:00 (at the age of 41-years-old) as 2nd dose, single for covid-19 immunization. The patient was not pregnant at the time of vaccination. The patient medical history included lupus, breast cancer and asthma; all from an unknown date. The patient had no known allergies. The patient had no covid-19 prior vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), administered in arm left on 01Apr2021 at 1:00 PM (at the age of 41-years-old) as 1st dose, single for covid-19 immunization. No other vaccine in four weeks and no other medications in two weeks. The patient's concomitant medications were not reported. The next day after receiving the second vaccine she ended up having an allergic reaction, which in turned into an infection in her arm on 23Apr2021 08:00. The events resulted in doctor or other health care professional office/clinic visit, emergency room/department or urgent care, hospitalization, prolongation of existing hospitalization (vaccine received during existing hospitalization). The patient was hospitalized for 3 days. The patient underwent lab tests and procedures which included sars-cov-2 test (nasal swab): unknown result (reported as pending) on 29Apr2021; and several tests: unknown results on Apr2021. The patient received antibiotics as treatment. The outcome of the events was not recovered.   Information about lot/batch number has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Heart rate increased, Insomnia
Clinical narrative: fainting; Extreme fatigue; chills; headache; insomnia; elevated resting heart rate; nausea; brain fog; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EW0162), via an unspecified route of administration, administered in right arm on 23Apr2021 08:15 as 2nd dose, single for COVID-19 immunization. The patient's medical history included allergic to chocolate. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ER8727), in the right arm on 02Apr2021 08:15 AM for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 was administered was clinic (Public Health Clinic/Veterans Administration facility). The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. There were no other medications received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced extreme fatigue, chills, headache, insomnia, elevated resting heart rate, nausea, fainting, brain fog, all on 23Apr2021 at 13:00. These started about 5 hours after injection, worsened for about 35 hours, then improved over the next 48 hours. No treatment was received for the events. The outcome of the events were recovered on an unspecified date.  Follow-up attempts are needed. Information about lot/batch number is available.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Syncope
Clinical narrative: fainting; Extreme fatigue; chills; headache; insomnia; elevated resting heart rate; nausea; brain fog; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EW0162), via an unspecified route of administration, administered in right arm on 23Apr2021 08:15 as 2nd dose, single for COVID-19 immunization. The patient's medical history included allergic to chocolate. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ER8727), in the right arm on 02Apr2021 08:15 AM for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 was administered was clinic (Public Health Clinic/Veterans Administration facility). The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. There were no other medications received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced extreme fatigue, chills, headache, insomnia, elevated resting heart rate, nausea, fainting, brain fog, all on 23Apr2021 at 13:00. These started about 5 hours after injection, worsened for about 35 hours, then improved over the next 48 hours. No treatment was received for the events. The outcome of the events were recovered on an unspecified date.  Follow-up attempts are needed. Information about lot/batch number is available.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Headache, Heart rate increased
Clinical narrative: fainting; Extreme fatigue; chills; headache; insomnia; elevated resting heart rate; nausea; brain fog; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EW0162), via an unspecified route of administration, administered in right arm on 23Apr2021 08:15 as 2nd dose, single for COVID-19 immunization. The patient's medical history included allergic to chocolate. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ER8727), in the right arm on 02Apr2021 08:15 AM for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 was administered was clinic (Public Health Clinic/Veterans Administration facility). The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. There were no other medications received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced extreme fatigue, chills, headache, insomnia, elevated resting heart rate, nausea, fainting, brain fog, all on 23Apr2021 at 13:00. These started about 5 hours after injection, worsened for about 35 hours, then improved over the next 48 hours. No treatment was received for the events. The outcome of the events were recovered on an unspecified date.  Follow-up attempts are needed. Information about lot/batch number is available.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Nausea, Syncope
Clinical narrative: fainting; Extreme fatigue; chills; headache; insomnia; elevated resting heart rate; nausea; brain fog; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EW0162), via an unspecified route of administration, administered in right arm on 23Apr2021 08:15 as 2nd dose, single for COVID-19 immunization. The patient's medical history included allergic to chocolate. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ER8727), in the right arm on 02Apr2021 08:15 AM for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 was administered was clinic (Public Health Clinic/Veterans Administration facility). The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. There were no other medications received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced extreme fatigue, chills, headache, insomnia, elevated resting heart rate, nausea, fainting, brain fog, all on 23Apr2021 at 13:00. These started about 5 hours after injection, worsened for about 35 hours, then improved over the next 48 hours. No treatment was received for the events. The outcome of the events were recovered on an unspecified date.  Follow-up attempts are needed. Information about lot/batch number is available.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia, Blood test normal, Chest X-ray normal, Electrocardiogram normal, Fatigue
Clinical narrative: transient heart arrhythmia usually lasting 5-15 seconds.; pronounced exhaustion; occasional mild headaches; This is a spontaneous report from a contactable consumer (patient). A 51-year-old male patient received the second dose of BNT162B2 (Lot Number: ER8729), via an unspecified route of administration, administered in left arm on 26Apr2021 17:00 (at the age of 51-year-old) at single dose for COVID-19 immunization. The patient medical history included insomnia. The patient had no known allergies. Concomitant medication included mirtazapine taken as sleep aid. The patient previously received the first dose of BNT162B2 (Lot Number: ER8734) administered in left arm on 05Apr2021 18:00 (at the age of 51-year-old) at single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Apr2021 19:00, the patient experienced pronounced exhaustion, occasional mild headaches, and a transient heart arrhythmia usually lasting 5-15 seconds.  These symptoms have not subsided, and the arrhythmia became persistent enough last night that it required a trip to the local ER. The consistent heart palpitations which ultimately brought him into the ER. The patient was referred to a local cardiologist and was told not to worry about the arrhythmia, that it would clear up in a few days. The reported events resulted in Emergency room/department or urgent care. There was no treatment received for the events. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was not recovered.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache
Clinical narrative: transient heart arrhythmia usually lasting 5-15 seconds.; pronounced exhaustion; occasional mild headaches; This is a spontaneous report from a contactable consumer (patient). A 51-year-old male patient received the second dose of BNT162B2 (Lot Number: ER8729), via an unspecified route of administration, administered in left arm on 26Apr2021 17:00 (at the age of 51-year-old) at single dose for COVID-19 immunization. The patient medical history included insomnia. The patient had no known allergies. Concomitant medication included mirtazapine taken as sleep aid. The patient previously received the first dose of BNT162B2 (Lot Number: ER8734) administered in left arm on 05Apr2021 18:00 (at the age of 51-year-old) at single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Apr2021 19:00, the patient experienced pronounced exhaustion, occasional mild headaches, and a transient heart arrhythmia usually lasting 5-15 seconds.  These symptoms have not subsided, and the arrhythmia became persistent enough last night that it required a trip to the local ER. The consistent heart palpitations which ultimately brought him into the ER. The patient was referred to a local cardiologist and was told not to worry about the arrhythmia, that it would clear up in a few days. The reported events resulted in Emergency room/department or urgent care. There was no treatment received for the events. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was not recovered.